Open | $1.820 |
Close | $1.920 |
Volume / Avg. | 63.747M / 22.102M |
Day Range | 1.740 - 2.040 |
52 Wk Range | 1.500 - 3.400 |
Market Cap | $1.442B |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 60 |
Short Interest | % |
Days to Cover | 5.93 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Tilray Brands (NASDAQ: TLRY) through any online brokerage.
Other companies in Tilray Brands’s space includes: Supernus Pharmaceuticals (NASDAQ:SUPN), WAVE Life Sciences (NASDAQ:WVE), Verona Pharma (NASDAQ:VRNA), Tarsus Pharmaceuticals (NASDAQ:TARS) and Neumora Therapeutics (NASDAQ:NMRA).
The latest price target for Tilray Brands (NASDAQ: TLRY) was reported by Roth MKM on Friday, September 1, 2023. The analyst firm set a price target for 2.50 expecting TLRY to rise to within 12 months (a possible 30.89% upside). 2 analyst firms have reported ratings in the last year.
The stock price for Tilray Brands (NASDAQ: TLRY) is $1.91 last updated March 18, 2024 at 7:59 PM EDT.
There are no upcoming dividends for Tilray Brands.
Tilray Brands’s Q3 earnings are confirmed for Monday, April 8, 2024.
There is no upcoming split for Tilray Brands.
Tilray Brands is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.